A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension

Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical Settings

(2010) D. Dunbar Ivy et al.   AMERICAN JOURNAL OF CARDIOLOGY

Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France

(2010) Alain Fraisse et al.   Archives of Cardiovascular Diseases

Predicting Survival in Pulmonary Arterial Hypertension

(2010) Raymond L. Benza et al.   CIRCULATION

Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertension

(2010) Sheila G Haworth et al.   CURRENT OPINION IN PULMONARY MEDICINE

Childhood idiopathic pulmonary arterial hypertension: a national cohort study

(2010) S. Moledina et al.   HEART

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study

(2009) Maurice Beghetti et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Safety of Maximal Cardiopulmonary Exercise Testing in Pediatric Patients With Pulmonary Hypertension

(2009) Gareth Smith et al.   CHEST

Clinical Characterization of Pediatric Pulmonary Hypertension: Complex Presentation and Diagnosis

(2009) Rosa Laura E. van Loon et al.   JOURNAL OF PEDIATRICS

Genetics and Genomics of Pulmonary Arterial Hypertension

(2009) Rajiv D. Machado et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diagnosis and Assessment of Pulmonary Arterial Hypertension

(2009) David B. Badesch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The 6-minute walk test: normal values for children of 4-11 years of age

(2007) A E Lammers et al.   ARCHIVES OF DISEASE IN CHILDHOOD